Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

41. Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review

Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review 27637772 2016 09 30 2017 03 15 2017 03 15 1836-9561 62 4 2016 Oct Journal of physiotherapy J Physiother Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review. 188-96 10.1016/j.jphys.2016.08.003 S1836-9553(16)30053-4 Does exercise improve postprandial glycaemic control in women diagnosed with gestational diabetes mellitus (...) ? A systematic review of randomised trials. Pregnant women diagnosed with gestational diabetes mellitus. Exercise, performed more than once a week, sufficient to achieve an aerobic effect or changes in muscle metabolism. Postprandial blood glucose, fasting blood glucose, glycated haemoglobin, requirement for insulin, adverse events and adherence. This systematic review identified eight randomised, controlled trials involving 588 participants; seven trials (544 participants) had data that were suitable

EvidenceUpdates2016

42. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.

Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. BACKGROUND: Gestational diabetes mellitus (GDM) is any degree of glucose intolerance that first presents and is recognised during pregnancy and usually resolves after the birth of the baby. GDM is associated with increased short- and long-term morbidity for the mother and her baby. Treatment usually includes lifestyle modification and/or pharmacological therapy (oral antidiabetic agents (...) , for the mother and fetus, in treating gestational diabetes. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2016), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (7 April 2016), and reference lists of retrieved studies. SELECTION CRITERIA: All published and unpublished randomised controlled trials or cluster-randomised controlled trials reporting on the use of myo-inositol compared with placebo, no treatment or another

Cochrane2016

43. External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study.

External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. OBJECTIVE: To perform an external validation and direct comparison of published prognostic models for early prediction of the risk of gestational diabetes mellitus, including predictors applicable in the first trimester of pregnancy. DESIGN: External validation of all published prognostic models in large scale, prospective, multicentre cohort study (...) 181 (4.9%) developed gestational diabetes mellitus in pregnancy. 12 prognostic models for the disorder could be validated in the cohort. C statistics ranged from 0.67 to 0.78. Calibration plots showed that eight of the 12 models were well calibrated. The four models with the highest C statistics included almost all of the following predictors: maternal age, maternal body mass index, history of gestational diabetes mellitus, ethnicity, and family history of diabetes. Prognostic models had a similar

BMJ2016 Full Text: Link to full Text with Trip Pro

44. Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus

Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus 27538169 2017 12 07 2018 11 13 1539-3704 165 4 2016 08 16 Annals of internal medicine Ann. Intern. Med. Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus. 299-300 10.7326/L16-0106 Gunderson Erica P EP Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy Investigators eng R01 HD050625 HD NICHD NIH HHS United States Journal Article Comment United (...) States Ann Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2015 Dec 15;163(12):889-98 26595611 Ann Intern Med. 2016 Aug 16;165(4):299 27538168 Am J Psychiatry. 2001 Jun;158(6):848-56 11384888 Matern Child Health J. 2009 May;13(3):334-42 18473131 BMC Public Health. 2011 Dec 23;11:952 22196129 Ann Intern Med. 2015 Dec 15;163(12):889-98 26595611 Breast Feeding Diabetes Mellitus, Type 2 Diabetes, Gestational Disease Progression Female Humans Lactation Pregnancy 2016 8 19 6 0 2016 8 19 6 0 2017 12 8 6

Annals of Internal Medicine2016 Full Text: Link to full Text with Trip Pro

45. Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus

Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus 27208340 2016 05 25 2016 12 02 1935-5548 39 6 2016 Jun Diabetes care Diabetes Care Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. 1052-5 10.2337/dc15-2672 To characterize physiologic subtypes of gestational diabetes mellitus (GDM). Insulin sensitivity and secretion were estimated in 809 women at 24-30 weeks' gestation, using oral (...) (57.6 vs. 28.2%, P = 0.003); differences were independent of BMI. Women with predominant insulin secretion defects (30% of GDM) had BMI, fasting glucose, infant birth weights, and risk of adverse outcomes similar to those in women with NGT. Heterogeneity of physiologic processes underlying hyperglycemia exists among women with GDM. GDM with impaired insulin sensitivity confers a greater risk of adverse outcomes. © 2016 by the American Diabetes Association. Readers may use this article as long

EvidenceUpdates2016 Full Text: Link to full Text with Trip Pro

46. Different intensities of glycaemic control for women with gestational diabetes mellitus.

Different intensities of glycaemic control for women with gestational diabetes mellitus. BACKGROUND: Gestational diabetes mellitus (GDM) has major short- and long-term implications for both the mother and her baby. GDM is defined as a carbohydrate intolerance resulting in hyperglycaemia or any degree of glucose intolerance with onset or first recognition during pregnancy from 24 weeks' gestation onwards and which resolves following the birth of the baby. Rates for GDM can be as high as 25 (...) RESULTS: We included one Canadian trial of 180 women, recruited between 20 to 32 weeks' gestation, who had been diagnosed with GDM. Data from 171 of the 180 women were published as a conference abstract and no full report has been identified. The overall risk of bias of the single included study was judged to be unclear.The included trial did not report on any of this review's primary outcomes. For the mother, these were hypertension disorders of pregnancy or subsequent development of type 2 diabetes

Cochrane2016

47. Short-term risk of cancer among women with previous gestational diabetes: a population-based study

Short-term risk of cancer among women with previous gestational diabetes: a population-based study 25970380 2016 01 15 2016 10 18 2016 12 30 1464-5491 33 1 2016 Jan Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Short-term risk of cancer among women with previous gestational diabetes: a population-based study. 39-46 10.1111/dme.12796 To evaluate the relationship between gestational diabetes (GDM) and incidence of cancer in women within the first decade postpartum (...) College Research Institute, Women's College Hospital, Toronto, ON, Canada. eng MOP#123263 Canadian Institutes of Health Research Canada Comparative Study Journal Article Research Support, Non-U.S. Gov't 2015 06 15 England Diabet Med 8500858 0742-3071 IM Adult Breast Neoplasms epidemiology etiology Cohort Studies Diabetes, Gestational physiopathology Female Follow-Up Studies Humans Incidence Kaplan-Meier Estimate Middle Aged Ontario epidemiology Postpartum Period Pregnancy Pregnancy in Diabetics

EvidenceUpdates2016

48. Pre-pregnancy potato consumption and risk of gestational diabetes mellitus: prospective cohort study.

Pre-pregnancy potato consumption and risk of gestational diabetes mellitus: prospective cohort study. STUDY QUESTION: What is the association between potato consumption before pregnancy and the risk of gestational diabetes mellitus (GDM)? METHODS: This prospective cohort study included 15,632 women from the Nurses' Health Study II (1991-2001). They had no previous GDM or chronic diseases before pregnancy. Consumption of potatoes and other foods was assessed every four years. Incident first time (...) , and whole grain foods was significantly associated with a 9-12% lower risk of GDM. Consumption and diabetes were self reported, and severity of diabetes was unknown. More than 90% of women were white. A causal association cannot be assumed. WHAT THIS PAPER ADDS: Higher levels of potato consumption before pregnancy are associated with greater risk of GDM, and substitution of potatoes with other vegetables, legumes, or whole grain foods might lower the risk. FUNDING, COMPETING INTERESTS, DATA SHARING

BMJ2016 Full Text: Link to full Text with Trip Pro

49. The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial

The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial 26657945 2015 12 23 2016 06 01 2017 05 18 1935-5548 39 1 2016 Jan Diabetes care Diabetes Care The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes (...) ' Effects on Moms (GEM) Cluster Randomized Controlled Trial. 65-74 10.2337/dc15-1254 To compare the effectiveness of diabetes prevention strategies addressing postpartum weight retention for women with gestational diabetes mellitus (GDM) delivered at the health system level: mailed recommendations (usual care) versus usual care plus a Diabetes Prevention Program (DPP)-derived lifestyle intervention. This study was a cluster randomized controlled trial of 44 medical facilities (including 2,280 women

EvidenceUpdates2016 Full Text: Link to full Text with Trip Pro

50. Randomized clinical trial: Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus

Randomized clinical trial: Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus Article Text Therapeutics/Prevention Randomized clinical trial Detemir is non-inferior to NPH insulin in women

Evidence-Based Medicine (Requires free registration)2016

51. Large-for-Gestational-Age Ultrasound Diagnosis and Risk for Cesarean Delivery in Women With Gestational Diabetes Mellitus

Large-for-Gestational-Age Ultrasound Diagnosis and Risk for Cesarean Delivery in Women With Gestational Diabetes Mellitus 26444129 2015 10 23 2016 02 04 2016 11 25 1873-233X 126 5 2015 Nov Obstetrics and gynecology Obstet Gynecol Large-for-Gestational-Age Ultrasound Diagnosis and Risk for Cesarean Delivery in Women With Gestational Diabetes Mellitus. 978-86 10.1097/AOG.0000000000001097 To assess the accuracy of a large-for-gestational-age (LGA) ultrasound diagnosis and the subsequent risk (...) for cesarean delivery associated with ultrasound diagnosis of LGA among women with gestational diabetes mellitus. This was a retrospective cohort study of 903 women with GDM who delivered after 36 weeks of gestation with an ultrasound-estimated fetal weight within 31 days of delivery. Delivery outcomes were compared between women with an ultrasound diagnosis of LGA and a non-LGA ultrasound diagnosis. Based on ultrasound assessments, we identified 248 women with an LGA fetus and 655 women with a non-LGA

EvidenceUpdates2015 Full Text: Link to full Text with Trip Pro

52. Does exercise during pregnancy decrease the incidence of gestational diabetes mellitus?

Does exercise during pregnancy decrease the incidence of gestational diabetes mellitus? Does exercise during pregnancy decrease the incidence of gestational diabetes mellitus? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Does exercise during pregnancy decrease the incidence of gestational diabetes mellitus? View (...) / Open Date 2015-09 Format Metadata Abstract Does exercise during pregnancy decrease the incidence of gestational diabetes mellitus? Evidence-Based Answer: When added to standard prenatal care, exercise programs do not affect the incidence of gestational diabetes mellitus (GDM) (SOR: A, meta analysis of RCTs). However, women who are more active before and at the beginning of pregnancy may have lower rates of GDM than less active women (SOR: C, prospective cohorts, case-controls, and cross-sectional

Evidence Based Practice 2015

54. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial

Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial 26223239 2015 12 23 2016 06 01 2017 06 15 1935-5548 39 1 2016 Jan Diabetes care Diabetes Care Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL): A Randomized Controlled Trial. 24-30 10.2337/dc15-0511 To assess whether gestational diabetes mellitus (GDM (...) -Lempinen Beata B Department of Obstetrics and Gynecology, South Karelia Central Hospital, Lappeenranta, Finland. eng ClinicalTrials.gov NCT01698385 Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't 2015 07 29 United States Diabetes Care 7805975 0149-5992 IM Ann Intern Med. 2015 Dec 15;163(12):JC7 26666809 Diabetes Care. 2017 Jun 14;: 28615238 Adult Body Mass Index Counseling Diabetes, Gestational epidemiology prevention & control Diet Female Finland epidemiology Glucose

EvidenceUpdates2015 Full Text: Link to full Text with Trip Pro

55. Guideline Supplement: Gestational diabetes mellitus

Guideline Supplement: Gestational diabetes mellitus Maternity and Neonatal C linical G uideline Department of Health Supplement: Gestational diabetes mellitus Queensland Clinical Guideline Supplement: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 2 of 12 Table of Contents 1 Introduction 3 1.1 Funding 3 1.2 Conflict of interest 3 1.3 Guideline review 3 2 Methodology 4 2.1 Topic identification 4 2.2 Scope 4 2.3 Clinical questions 4 2.4 Exclusions 4 (...) ) 3234 1479. Queensland Clinical Guideline Supplement: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 3 of 12 1 Introduction This document is a supplement to the Queensland Clinical Guideline Gestational diabetes mellitus (GDM). It provides supplementary information regarding guideline development, makes summary recommendations, suggests measures to assist implementation and quality activities and summarises changes (if any) to the guideline since

Queensland Health2015

56. Systematic review with meta analysis: In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin

Systematic review with meta analysis: In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you (...) are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin

Evidence-Based Medicine (Requires free registration)2015

57. Growing evidence that maternal gestational diabetes increases risk of autism in offspring

Growing evidence that maternal gestational diabetes increases risk of autism in offspring Growing evidence that maternal gestational diabetes increases risk of autism in offspring | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Growing evidence that maternal gestational diabetes increases risk of autism in offspring Article Text Causes and risk factors Growing evidence that maternal gestational diabetes increases risk of autism in offspring Andrea L Roberts , Vy T Nguyen Statistics from Altmetric.com No Altmetric data available for this article

Evidence-Based Mental Health2015

58. Flowchart: Gestational diabetes mellitus postpartum care

Flowchart: Gestational diabetes mellitus postpartum care Document Number: F15.33-3-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Postpartum care for all GDM Cease Metformin and/or Insulin immediately after birth (vaginal or CS) BGL monitoring • Target BGL = 7.0 mmol/L • Monitor BGL QID for 24 hours (preprandial (...) and before bed) • If all preprandial BGL between 4-7 mmol/L, cease monitoring 24 hours after birth BGL 7.0 mmol/L • If any preprandial BGL > 7.0 mmol/L o Seek medical review o Continue BGL monitoring • Insulin rarely required postpartum o If indicated, prescribe lower dose than required during pregnancy IV therapy (if any) • If BGL = 4.0 mmol/L and diet tolerated cease mainline IV fluids after birth All GDM Pharmacological therapy? Insulin or Metformin Queensland Clinical Guideline: Gestational diabetes

Queensland Health2015

59. Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin

Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin Document Number: F15.33--2-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease when labour established Insulin • Cease when labour

Queensland Health2015

60. Flowchart: Gestational diabetes mellitus, screening and Diagnosis

Flowchart: Gestational diabetes mellitus, screening and Diagnosis Document Number: F15.33-1-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Screening and diagnosis of GDM 24-28 weeks gest 2 hour 75 g OGTT Routine antenatal care Risk factors? OGTT normal? BGL: Blood glucose level BMI: Body Mass Index DM: Diabetes (...) Mellitus GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestational diabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable) • 1st trimester only • Result = 41 mmol/mol

Queensland Health2015